Coronavirus: China’s Sinovac investing US$60 million in Chile vaccine facility

[Yongpeng Sun-Tastaufen]

China’s Sinovac investing US$60 million in Chile vaccine facility

The Latin American nation bet big on the Chinese company’s CoronaVac shot, with 19.6 million doses already delivered.

www.scmp.com

• The plant will be built in the Santiago region in early 2022. Sinovac will also build a research and development centre in the northern region of Antofagasta
• The Chilean government bet big on the Chinese company’s CoronaVac shot, with 19.6 million doses already delivered

Chinese pharmaceutical Sinovac Biotech on Wednesday said it will build a fill-and-finish vaccine plant in Chile with an investment of US$60 million, consolidating its presence in the Latin American nation that has used its Covid-19 shot the most.
Chile has run one of the world’s fastest vaccination campaigns, so far fully vaccinating more than 60 per cent of its population, including with 19.6 million doses of Sinovac’s CoronaVac already delivered.
The plant will be built in the Santiago region in the first quarter of 2022.
Sinovac will also build a research and development centre in the northern region of Antofagasta.


Since mid-July, Sinovac executives have been looking at the possibility of building a plant in Chile with a capacity to produce 50 million vaccines of diverse types.


The Chilean government bet big on Sinovac’s
Covid-19 vaccine
, part-funding along with local businesses CoronaVac’s trial in the country, and ordering 60 million doses of the drug over the next three years, later topping up with more orders.

Chinese pharmaceutical Sinovac Biotech on Wednesday said it will build a fill-and-finish vaccine plant in Chile with an investment of US$60 million, consolidating its presence in the Latin American nation that has used its Covid-19 shot the most.
Chile has run one of the world’s fastest vaccination campaigns, so far fully vaccinating more than 60 per cent of its population, including with 19.6 million doses of Sinovac’s CoronaVac already delivered.
The plant will be built in the Santiago region in the first quarter of 2022.
Sinovac will also build a research and development centre in the northern region of Antofagasta.

Since mid-July, Sinovac executives have been looking at the possibility of building a plant in Chile with a capacity to produce 50 million vaccines of diverse types.

The Chilean government bet big on Sinovac’s
Covid-19 vaccine
, part-funding along with local businesses CoronaVac’s trial in the country, and ordering 60 million doses of the drug over the next three years, later topping up with more orders.

The health ministry has also indicated it will consider issuing third doses of vaccines to bolster their effectiveness in the face of new variants such as the Delta strain presently nudging up infection rates around the world.

Data released by the Chilean government on Tuesday suggested CoronaVac’s effectiveness at preventing symptomatic infection among its recipients fell from 67 per cent when measured between February and April, to 58.5 per cent when measured again at the start of July.